Personalized pharmacotherapy of arterial hypertension patients with musculoskeletal system diseases based on pharmacogenetic aspects

Author:

Muratov K. M.1ORCID,Stuk I. V.1,Lapudus N. I.1ORCID

Affiliation:

1. Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University)

Abstract

Pharmacotherapy in patients with comorbidity is a current issue for clinical practice. Combination of hypertension and musculoskeletal diseases can be found in 40% of outpatients, which requires simultaneous administration of different drugs. The main mechanisms of drug interactions are associated with pharmacokinetics or pharmacodynamics alterations. It has been proven that changes in drugs pharmacokinetics can be due to cytochromes P450 activity. The main symptom of musculoskeletal diseases is chronic pain, which requires long-term therapy with non-steroidal anti-inflammatory drugs (NSAIDs). The 2C19 isoenzyme takes part in metabolism of some NSAIDs. Losartan, the inhibitor of renin-angiotensinaldosterone system (RAAS), is also metabolized by the 2C9 isoenzyme and is quite often prescribed to outpatients to treat hypertension. Hence, an influence of genetic factors on efficacy and safety of antihypertensive drugs and NSAIDs combinations requires further studies.

Publisher

Publishing House OKI

Subject

General Medicine

Reference38 articles.

1. World Health Organization. Guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva: WHO; 2017.

2. Rodionov АV. Non-steroid antipyretic preparations and arterial hypertension: actual character of the problem and the strategy of conducting patients. Lechashchij vrach. 2013;(2):25 (In Russ).

3. Khutsishvily MSh, Baturin VA. Pharmacoepidemiological study of nonsteroid antiinflammatory medicine use in the in-patient department before and after the formular system adoption. Saratovskij nauchno-medicinskij zhurnal. 2008;19(1):130–134. (In Russ).

4. Harley C, Wagner S. The prevalence of cardiovascular risk factors in patients prescribing anti-inflammatory drugs: data from managed care. Clin Ther. 2003;25(1):139–149. DOI: 10.1016/s0149-2918(03)90017-890017-8.

5. Curhan G, Willet W, Rosner B, Stampfer M. Frequency оf analgesic use and risk of hypertension in younger woman. Arch Intern Med. 2002;162(19):2204–2208. DOI: 10.1001/archinte.162.19.2204.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3